Omnicell, Inc. (OMCL): Price and Financial Metrics

Omnicell, Inc. (OMCL): $34.72

0.11 (+0.32%)

POWR Rating

Component Grades








Add OMCL to Watchlist
Sign Up

Industry: Medical - Services




#28 of 65

in industry

OMCL Price/Volume Stats

Current price $34.72 52-week high $77.14
Prev. close $34.61 52-week low $28.72
Day low $34.36 Volume 498,100
Day high $35.62 Avg. volume 526,300
50-day MA $38.59 Dividend yield N/A
200-day MA $56.78 Market Cap 1.58B

OMCL Stock Price Chart Interactive Chart >


  • OMCL scores best on the Value dimension, with a Value rank ahead of 91.63% of US stocks.
  • The strongest trend for OMCL is in Value, which has been heading up over the past 177 days.
  • OMCL ranks lowest in Momentum; there it ranks in the 9th percentile.

OMCL Stock Summary

  • Over the past twelve months, OMCL has reported earnings growth of -204.7%, putting it ahead of merely 7.07% of US stocks in our set.
  • As for revenue growth, note that OMCL's revenue has grown -9.42% over the past 12 months; that beats the revenue growth of just 22.66% of US companies in our set.
  • The volatility of OMNICELL INC's share price is greater than that of 71.85% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to OMNICELL INC, a group of peers worth examining would be ASPN, HEAR, EAR, ECOR, and ACON.
  • Visit OMCL's SEC page to see the company's official filings. To visit the company's web site, go to

OMCL Valuation Summary

  • In comparison to the median Healthcare stock, OMCL's EV/EBIT ratio is 413.71% lower, now standing at -30.9.
  • OMCL's price/earnings ratio has moved up 5.7 over the prior 243 months.

Below are key valuation metrics over time for OMCL.

Stock Date P/S P/B P/E EV/EBIT
OMCL 2023-11-03 1.2 1.2 -40.2 -30.9
OMCL 2023-11-02 1.1 1.1 -57.0 -43.5
OMCL 2023-11-01 1.3 1.4 -69.8 -51.9
OMCL 2023-10-31 1.3 1.4 -69.3 -51.6
OMCL 2023-10-30 1.3 1.4 -68.8 -51.3
OMCL 2023-10-27 1.3 1.4 -68.0 -50.7

OMCL Growth Metrics

    Its 2 year cash and equivalents growth rate is now at 154.62%.
  • Its year over year price growth rate is now at -20.33%.
  • Its year over year net income to common stockholders growth rate is now at 105.47%.
OMCL's revenue has moved up $535,804,000 over the prior 49 months.

The table below shows OMCL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,309.307 55.26 48.037
2022-06-30 1,257.65 77.074 60.58
2022-03-31 1,199.003 158.398 71.935
2021-12-31 1,132.018 231.809 77.849
2021-09-30 1,070.186 248.625 80.245
2021-06-30 987.483 242.323 59.733

OMCL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OMCL has a Quality Grade of C, ranking ahead of 58.08% of graded US stocks.
  • OMCL's asset turnover comes in at 0.534 -- ranking 55th of 83 Computers stocks.
  • STRM, PBI, and CERN are the stocks whose asset turnover ratios are most correlated with OMCL.

The table below shows OMCL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.534 0.485 0.087
2021-03-31 0.550 0.466 0.054
2020-12-31 0.595 0.463 0.052
2020-09-30 0.658 0.464 0.064
2020-06-30 0.734 0.473 0.105
2020-03-31 0.752 0.486 0.148

OMCL Price Target

For more insight on analysts targets of OMCL, see our OMCL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $167.50 Average Broker Recommendation 1.55 (Moderate Buy)

Omnicell, Inc. (OMCL) Company Bio

Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.

OMCL Latest News Stream

Event/Time News Detail
Loading, please wait...

OMCL Latest Social Stream

Loading social stream, please wait...

View Full OMCL Social Stream

Latest OMCL News From Around the Web

Below are the latest news stories about OMNICELL INC that investors may wish to consider to help them evaluate OMCL as an investment opportunity.

Omnicell's (OMCL) Portfolio Expansion Aids Amid Macro Woes

Omnicell (OMCL) accelerates its shift to cloud-based solutions and tech-enabled services through the launch of Inventory Optimization Service and Central Pharmacy Dispensing Services.

Yahoo | November 16, 2023

Here's Why You Should Retain Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL) due to its technology and innovative solutions.

Yahoo | November 16, 2023

Here’s Why Conestoga Capital Advisors Sold Omnicell (OMCL)

Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The Small Cap Composite returned -6.72% net-of-fees in the third quarter, compared to the Russell 2000 Growth Index’s -7.32% return. The strategy’s outperformance was driven by positive stock selection effects, while sector […]

Yahoo | November 15, 2023

Omnicell, Inc. (NASDAQ:OMCL) Q3 2023 Earnings Call Transcript

Omnicell, Inc. (NASDAQ:OMCL) Q3 2023 Earnings Call Transcript November 5, 2023 Operator: Good morning, my name is Jordan, and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Omnicell Third Quarter Earnings Call. I’ll be turning the call over to Kathleen Nemeth, Senior Vice President of Investor Relations. […]

Yahoo | November 6, 2023

Some Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Made A Major Cut To Next Year's Estimates

The latest analyst coverage could presage a bad day for Omnicell, Inc. ( NASDAQ:OMCL ), with the analysts making...

Yahoo | November 5, 2023

Read More 'OMCL' Stories Here

OMCL Price Returns

1-mo -2.31%
3-mo -39.13%
6-mo -53.07%
1-year -32.73%
3-year -66.89%
5-year -55.04%
YTD -31.14%
2022 -72.06%
2021 50.34%
2020 46.87%
2019 33.44%
2018 26.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!